VCEL

Vericel
VCEL

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.01B
EV
$1.99B
Shares Outstanding
51.41M
Beta
1.62

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$63.25
P/E 2025E
123.87x
P/Revenue 2025E
7.01x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Vericel Corporation

gainify
VCEL

Vericel Corporation

VCEL

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy ...

Sector

Healthcare

Industry

Biotechnology

CEO

Colangelo, Dominick

Employees

357

Website

vcel.com

IPO Date

1997-02-04

Headquarters

64 Sidney Street, Cambridge, Massachusetts, 02139, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved